[{"Assets_0_Q1_USD":"5805053000.0","CIK":"1048477","CommonStockSharesConverted_0_Q1_shares":"182670614.0","CommonStockSharesOutstanding_0_Q1_shares":"182670614.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"0.1","EarningsPerShareDiluted_1_Q1_USD":"0.09","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"113512000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"17371000.0","NetIncomeLoss_1_Q1_USD":"17371000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q1_USD":"486030000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q1_USD":"4162010000.0","Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"184365000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"181772000.0","filed":"20210430","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20210331","qtrs":"1","uom":"USD"}]